AACR Project GENIE
AACR Project GENIE® is an international, open-source pancancer registry of real-world clinico-genomic data that catalyzes discovery, informs regulatory strategy, and powers precision oncology.
Learn More
AACR Project GENIE® is an international, open-source pancancer registry of real-world clinico-genomic data that catalyzes discovery, informs regulatory strategy, and powers precision oncology.
Learn More
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe inaugural AACR Pediatric Cancer Progress Report highlights research-driven advances in the prevention, detection, and treatment of childhood cancers.
Read the ReportMore than 320,000 women in the U.S. will be diagnosed with breast cancer this year. October is Breast Cancer Awareness Month. Read about prevention, screening, and treatment options for breast cancer.
Learn MoreStopping Cancer in its Tracks: Can prevention and early detection significantly reduce the burden of cancer?
Learn More in AACR StoriesThe latest issue of Leading Discoveries highlights research-driven progress in cancer science and medicine.
Read Leading DiscoveriesWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe Call for Abstracts for the AACR Annual Meeting 2027 (April 2-7) is now available. Abstract Deadline: November 10
The AACR Cancer Progress Report 2026 highlights the remarkable progress against cancers driven by discoveries across basic, translational, clinical, and population science.
Learn MoreThe AACR and its more than 65,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Disparities Progress Report 2026 provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2024
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2025, to June 30, 2026
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 65,000 members worldwide drive progress against cancer.
Donate Now
